"/> Novus Biologicals™ Peptide bloquant d’anticorps CI… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps CIDEA

Réf. : BL-RE-103907Réf. fabricant : 18268875 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
1149
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76951. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 18 amino acids near the carboxy terminus of human CIDE-A.

Points forts

Source

Synthetic

(Accession #: AF041378) The CIDEA Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-103907
Réf. fabricant18268875
Gene ID (Entrez)1149
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76951. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènecell death activator CIDE-A, cell death-inducing DFFA-like effector aCIDE-A
Symbole de gène(s)CIDEA
Type de produitCIDEA
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne18 amino acids near the carboxy terminus of human CIDE-A
Une question, une configuration particulière ?
Contactez-nous pour un devis.